These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15126881)

  • 1. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.
    Park J; Chen L; Shade K; Lazarus P; Seigne J; Patterson S; Helal M; Pow-Sang J
    J Urol; 2004 Jun; 171(6 Pt 1):2484-8. PubMed ID: 15126881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer.
    MacLeod SL; Nowell S; Plaxco J; Lang NP
    Ann Surg Oncol; 2000 Dec; 7(10):777-82. PubMed ID: 11129427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
    Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.
    Hu DG; Mackenzie PI
    Drug Metab Dispos; 2010 Dec; 38(12):2105-9. PubMed ID: 20736324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.
    Pâquet S; Fazli L; Grosse L; Verreault M; Têtu B; Rennie PS; Bélanger A; Barbier O
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E428-32. PubMed ID: 22170718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
    Gauthier-Landry L; Bélanger A; Barbier O
    J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.
    Bao BY; Chuang BF; Wang Q; Sartor O; Balk SP; Brown M; Kantoff PW; Lee GS
    Prostate; 2008 Jun; 68(8):839-48. PubMed ID: 18302198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population.
    Okugi H; Nakazato H; Matsui H; Ohtake N; Nakata S; Suzuki K
    Cancer Detect Prev; 2006; 30(3):262-8. PubMed ID: 16859836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of UDP-Glucuronosyltransferase 2B15 by miR-331-5p in Prostate Cancer Cells Involves Canonical and Noncanonical Target Sites.
    Wijayakumara DD; Mackenzie PI; McKinnon RA; Hu DG; Meech R
    J Pharmacol Exp Ther; 2018 Apr; 365(1):48-59. PubMed ID: 29367276
    [No Abstract]   [Full Text] [Related]  

  • 10. UDP-glucuronosyltransferase 2B15 (UGT2B15) is the major enzyme responsible for sipoglitazar glucuronidation in humans: retrospective identification of the UGT isoform by in vitro analysis and the effect of UGT2B15*2 mutation.
    Nishihara M; Hiura Y; Kawaguchi N; Takahashi J; Asahi S
    Drug Metab Pharmacokinet; 2013; 28(6):475-84. PubMed ID: 23648677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.
    Wijayakumara DD; Hu DG; Meech R; McKinnon RA; Mackenzie PI
    J Pharmacol Exp Ther; 2015 Sep; 354(3):417-25. PubMed ID: 26163549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.
    Margaillan G; Lévesque É; Guillemette C
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):85-93. PubMed ID: 26385605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.
    Sparks R; Ulrich CM; Bigler J; Tworoger SS; Yasui Y; Rajan KB; Porter P; Stanczyk FZ; Ballard-Barbash R; Yuan X; Lin MG; McVarish L; Aiello EJ; McTiernan A
    Breast Cancer Res; 2004; 6(5):R488-98. PubMed ID: 15318931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.
    Lévesque E; Beaulieu M; Green MD; Tephly TR; Bélanger A; Hum DW
    Pharmacogenetics; 1997 Aug; 7(4):317-25. PubMed ID: 9295060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis.
    Zhong X; Feng J; Xiao Y; Wang P; Fan Q; Wu R; Hu W; Huang C
    Oncotarget; 2017 Aug; 8(32):52837-52845. PubMed ID: 28881775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer.
    Chen L; Elahi A; Pow-Sang J; Lazarus P; Park J
    J Urol; 2003 Dec; 170(6 Pt 1):2471-4. PubMed ID: 14634453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.
    Papageorgiou I; Court MH
    Biochem Pharmacol; 2017 Dec; 146():199-213. PubMed ID: 28962835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.
    Chouinard S; Barbier O; Bélanger A
    J Biol Chem; 2007 Nov; 282(46):33466-33474. PubMed ID: 17848572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.
    He X; Hesse LM; Hazarika S; Masse G; Harmatz JS; Greenblatt DJ; Court MH
    Br J Clin Pharmacol; 2009 Nov; 68(5):721-30. PubMed ID: 19916996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation.
    Hanioka N; Oka H; Nagaoka K; Ikushiro S; Narimatsu S
    Arch Toxicol; 2011 Nov; 85(11):1373-81. PubMed ID: 21404072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.